Announcement of call for proposals – Joint Canada-Israel Health Research Program Phase II – 2021-2022 competition
Phase II of JCIHRP seeks to support fundamental research at the cutting-edge of biomedical science and global health. Six grants worth up to CA$ 1.4 million each will be awarded to research teams based in Canada, Israel and low- and middle-income countries (LMICs) for a period of up to four years.
This first call for proposals under phase II is directed toward proposals at the intersection between non-communicable chronic diseases (NCDs) and infectious diseases, while strengthening research capacity in Canada, Israel and LMICs. Potential topics may include, but are not limited to the following:
Use of epidemiological and clinical data to gain insight into biological mechanisms influencing the intersection of chronic and infectious diseases.
Study of mechanisms driving the interactions between non-communicable chronic and infectious diseases.
Biomarkers and/or predictive factors of NCDs following infections or infection severity with pre-existing NCDs.
System biology approaches.
Proposals must be co-led by three independent investigators, one from Canada, Israel and an eligible LMIC. Teams are required to establish a knowledge mobilization plans. This could include a range of activities that support research, training and exchange, while taking advantage of this funding opportunity to design a collaborative international research project.
Further details on the call and detailed guidelines for submission are published on CIHR’s Funding Opportunity database. The application process for this funding opportunity is comprised of two steps: registration and application. In Canada, registrations are due March 3, 2022, and applications are due April 5, 2022. In Israel, registrations are due March 2, 2022, and applications are due April 4, 2022.
For further information, please contact:
Toll Free: 1-888-603-4178
Scientific Director Special Programs
Israel Science Foundation